124 related articles for article (PubMed ID: 22170313)
1. PpIX fluorescence combined with auto-fluorescence is more accurate than PpIX fluorescence alone in fluorescence detection of non-melanoma skin cancer: an intra-patient direct comparison study.
van der Beek N; de Leeuw J; Demmendal C; Bjerring P; Neumann HA
Lasers Surg Med; 2012 Apr; 44(4):271-6. PubMed ID: 22170313
[TBL] [Abstract][Full Text] [Related]
2. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of photodynamic diagnosis in defining the lateral border between a tumor and a tumor-free area during Mohs micrographic surgery.
Lee CY; Kim KH; Kim YH
Dermatol Surg; 2010 Nov; 36(11):1704-10. PubMed ID: 20840493
[TBL] [Abstract][Full Text] [Related]
4. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Barysch MJ
Praxis (Bern 1994); 2016 Sep; 105(18):1071-7. PubMed ID: 27606914
[No Abstract] [Full Text] [Related]
6. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
Harvey NT; Leecy T; Wood BA
Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
8. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring.
Lallas A; Argenziano G; Zendri E; Moscarella E; Longo C; Grenzi L; Pellacani G; Zalaudek I
Expert Rev Anticancer Ther; 2013 May; 13(5):541-58. PubMed ID: 23617346
[TBL] [Abstract][Full Text] [Related]
9. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
[TBL] [Abstract][Full Text] [Related]
10. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
11. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Tyrrell JS; Morton C; Campbell SM; Curnow A
Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
[TBL] [Abstract][Full Text] [Related]
12. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
13. Photodetection of basal cell carcinoma using methyl 5-aminolaevulinate-induced protoporphyrin IX based on fluorescence image analysis.
Won Y; Hong SH; Yu HY; Kwon YH; Yun SJ; Lee SC; Lee JB
Clin Exp Dermatol; 2007 Jul; 32(4):423-9. PubMed ID: 17459066
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage.
de Leeuw J; van der Beek N; Neugebauer WD; Bjerring P; Neumann HA
Lasers Surg Med; 2009 Feb; 41(2):96-103. PubMed ID: 19226578
[TBL] [Abstract][Full Text] [Related]
15. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
[TBL] [Abstract][Full Text] [Related]
16. [The wider application of photodynamic therapy in dermatology].
Thissen MR; Kuijpers DI; Neumann HA
Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
[TBL] [Abstract][Full Text] [Related]
17. Pathologic changes after photodynamic therapy for Basal cell carcinoma and Bowen disease: a histologic and immunohistochemical investigation.
Fantini F; Greco A; Cesinaro AM; Surrenti T; Peris K; Vaschieri C; Marconi A; Giannetti A; Pincelli C
Arch Dermatol; 2008 Feb; 144(2):186-94. PubMed ID: 18283175
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
19. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.
Smits T; van Laarhoven AI; Staassen A; van de Kerkhof PC; van Erp PE; Gerritsen MJ
Br J Dermatol; 2009 Apr; 160(4):849-57. PubMed ID: 19175603
[TBL] [Abstract][Full Text] [Related]
20. Phasor-FLIM as a Screening Tool for the Differential Diagnosis of Actinic Keratosis, Bowen's Disease, and Basal Cell Carcinoma.
Luo T; Lu Y; Liu S; Lin D; Qu J
Anal Chem; 2017 Aug; 89(15):8104-8111. PubMed ID: 28661125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
